The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neurocognitive testing to predict ICANS post-CAR T.
 
William Wesson
No Relationships to Disclose
 
Lauren Scott
No Relationships to Disclose
 
Nahid Suleman
No Relationships to Disclose
 
Shaun DeJarnette
No Relationships to Disclose
 
Al-Ola A. Abdallah
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Sanofi (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - PSA vaccine patent
 
Forat Umair Lutfi
No Relationships to Disclose
 
Sunil H. Abhyankar
Stock and Other Ownership Interests - Johnson and Johnson; Lilly; Merck; Pfizer
Consulting or Advisory Role - Kite, a Gilead company
Speakers' Bureau - Incyte; Therakos
Research Funding - CSL Behring
Travel, Accommodations, Expenses - Incyte; Therakos
 
Leyla Shune
Consulting or Advisory Role - Janssen Oncology
 
Muhammad Umair Mushtaq
No Relationships to Disclose
 
Anurag Kumar Singh
No Relationships to Disclose
 
Haitham Abdelhakim
No Relationships to Disclose
 
Joseph McGuirk
Honoraria - AlloVir; Kite, a Gilead company; Magenta Therapeutics; Nektar; Sana Biotechnology
Consulting or Advisory Role - Allovir; crispr therapeutics; EcoR1 Capital; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Speakers' Bureau - Kite/Gilead
Research Funding - AlloVir (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; SITC/ACCC; Syncopation Life Sciences
 
Muhammad Nashatizadeh
No Relationships to Disclose
 
Elizabeth M Muenks
No Relationships to Disclose
 
Hannah Katz
No Relationships to Disclose
 
Nausheen Ahmed
Consulting or Advisory Role - BMS; Kite/ Gilead
Research Funding - Kite/Gilead (Inst)